Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia.Blood Cancer J. 2017 Feb 03; 7(2):e526.BC
Links
Pub Type(s)
Clinical Trial
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Validation Study
Language
eng
PubMed ID
28157213
Citation
Sfeir, J G., et al. "Validation of a Vitamin D Replacement Strategy in Vitamin D-insufficient Patients With Lymphoma or Chronic Lymphocytic Leukemia." Blood Cancer Journal, vol. 7, no. 2, 2017, pp. e526.
Sfeir JG, Drake MT, LaPlant BR, et al. Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia. Blood Cancer J. 2017;7(2):e526.
Sfeir, J. G., Drake, M. T., LaPlant, B. R., Maurer, M. J., Link, B. K., Berndt, T. J., Shanafelt, T. D., Cerhan, J. R., Habermann, T. M., Feldman, A. L., & Witzig, T. (2017). Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia. Blood Cancer Journal, 7(2), e526. https://doi.org/10.1038/bcj.2017.9
Sfeir JG, et al. Validation of a Vitamin D Replacement Strategy in Vitamin D-insufficient Patients With Lymphoma or Chronic Lymphocytic Leukemia. Blood Cancer J. 2017 02 3;7(2):e526. PubMed PMID: 28157213.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia.
AU - Sfeir,J G,
AU - Drake,M T,
AU - LaPlant,B R,
AU - Maurer,M J,
AU - Link,B K,
AU - Berndt,T J,
AU - Shanafelt,T D,
AU - Cerhan,J R,
AU - Habermann,T M,
AU - Feldman,A L,
AU - Witzig,T,
Y1 - 2017/02/03/
PY - 2017/2/4/entrez
PY - 2017/2/6/pubmed
PY - 2018/8/28/medline
SP - e526
EP - e526
JF - Blood cancer journal
JO - Blood Cancer J
VL - 7
IS - 2
SN - 2044-5385
UR - https://www.unboundmedicine.com/medline/citation/28157213/full_citation
DB - PRIME
DP - Unbound Medicine
ER -
Try the Free App:
